Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 28 Aug 2023 Conference abstract · 2021 Designing and Development of Sublingual Dosage Forms of Poorly-Soluble Drugs with High Hepatic First-Pass Metabolism
Statement of Problem: Poor solubility and first-pass metabolism are major concerns for formulation scientists during development of oral dosage forms. To overcome these challenges, many drugs are formulated
Commentary · 1 Aug 2022 First-Pass Metabolism of Alcohol Occurs in Women's Stomachs, Study Finds
Opinion · 29 Jun 2023 Understanding the Pharmacokinetic Profile of Fluticasone: Implications for Therapeutic Efficacy and Safety
absorption, distribution, metabolism, and elimination. Fluticasone exhibits high oral bioavailability, with minimal first-pass metabolism, when administered orally. However, it is predominantly administered via…
Article · 7 Jul 2026 Optimizing Bioavailability for Drug Development Success
formulations (nanoparticles, solid dispersions) and understanding food-drug interactions are key to enhancement. First-pass metabolism and gastrointestinal tract complexities present challenges, addressed through…
Opinion · 30 Oct 2024 The Role of Oral Bioavailability in Drug Development: Challenges and Solutions for Improving Patient Outcomes
advantages of oral administration, several challenges hinder optimal bioavailability, including poor solubility, extensive first-pass metabolism, and drug stability issues. This review explores the multifaceted role of…
Conference abstract · 5 Oct 2018 Iontophoresis: Rediscovering the transdermal drug delivery system
edge over injectable and oral routes by enhancing patient compliance and bypassing the first-pass metabolism respectively. Iontophoresis (IOP) is one of the most popularly preferred TDDS, which uses electric
Short communication · 29 Mar 2025 Bioavailability Enhancement: Optimizing Drug Effectiveness
intestinal epithelium or blood-brain barrier, thereby improving systemic absorption [4]. First-pass metabolism in the liver and gastrointestinal tract is another factor that reduces bioavailability. Alternative delivery…
Conference abstract · 18 Oct 2017 Oral nanocarrier for insulin colon delivery
oral administration may lead to a better glucose regulation exploiting the liver first-pass metabolism of insulin, thus preventing the risks of fluctuating glycaemia. However, the oral bioavailability of peptides
Opinion · 28 Mar 2024 An overview on Mucosal Drug Delivery for Enhanced Therapeutic Outcomes
invasive route of drug administration offers several advantages, including rapid absorption, avoidance of first-pass metabolism, and targeted delivery to specific anatomical sites. In this article, we delve into…
Research article · 30 Nov 2021 Preparation and in vitro Evaluation of Darifenacin HBr as Nanoparticles Prepared as Nanosuspension
receptors. After intravenous and immediate-release oral dose forms, it suffers from extensive first-pass metabolism with a short elimination half-life and ranging between three to four hours
Editorial · 30 Mar 2025 Bioavailability: Key Determinant of Drug Efficacy and Therapeutic Performance
regimens, and clinical outcomes[1]. Factors affecting bioavailability include drug formulation, solubility, permeability, first-pass metabolism, and patientspecific physiological variables. Analytical methods such as…
Editorial · 29 Sep 2025 Nanoemulsions, Oral Drug Delivery, and Bioavailability
oral bioavailability because of low solubility, instability in the gastrointestinal tract, and extensive first-pass metabolism. Bioavailability refers to the fraction of an administered dose that reaches systemic…
Perspective · 29 Jun 2025 Intranasal Drug Delivery: A Promising Route for Therapeutics
large surface area for absorption, high vascularization, and the ability to bypass first-pass hepatic metabolism. These characteristics enable rapid onset of action and improved bioavailability for many drugs…
Mini review · 30 Dec 2023 Inhaled Drug Pharmacokinetics
therapeutic outcomes. Metabolism ofinhaled drugs takes a unique trajectory, escaping the confines of first-pass metabolism in the liver. Pulmonarymetabolism may contribute to the overall fate of these drugs, adding
Conference abstract Lipid based nanoparticles for improved oral bioavailability of pharmaceuticals
lymphatic transport, which delivers drug directly to systemic circulation while avoiding hepatic first-pass metabolism, and by increasing GI membrane permeability. Lipid nanoparticles compared with other nano or…
Mini review · 28 Feb 2024 Unraveling the Dynamics: Understanding Fluticasone Pharmacokinetics
absorption following inhalation or intranasal administration, with minimal systemic exposure due to extensive first-pass metabolism. Its distribution is primarily limited to tissues with high glucocorticoid receptor…
Review article · 29 Jun 2023 Pharmacokinetics of Olanzapine: A Comprehensive Review
gastrointestinal tract. Its bioavailability is high, reaching approximately 60-65% due to first-pass metabolism. Food intake does not significantly affect its absorption. Once absorbed, olanzapine exhibits a large volume
Article · 30 Jun 2025 Pharmacokinetics and Pharmacodynamics: Foundations of Drug Action
body and their biological effects, respectively. Pharmacokinetics focuses on the absorption, distribution, metabolism, and excretion (ADME) of drugs, determining how the body handles a therapeutic agent…
Research article · 2014 TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW
obvious advantages e.g.convenient and pain-free self-administration for patients, avoidance of hepatic first-pass metabolism and the GI tract for poorly bioavailable drugs over other routes of delivery
Conference abstract Fate of pharmacologically active isoflavones upon administration in sprague dawley rats
rapidly metabolized by the liver. The high clearance is likely due to rapid metabolism of BCA. Upon de-conjugation of plasma samples using glucuronidase/sulfatase ... administration. The poor bioavailability of FMN and…
Article · 2012 47. Formulation and Evaluation of Mucoadhesive Buccal Bilayered Tablets of Salbutamol
disease. The salbutamol buccal mucoadhesive tablets were fabricated with objective of avoiding first pass metabolism and prolonging duration of action. Salbutamol mucoadhesive bilayered tablets were prepared by direct…
Editorial · 29 Sep 2025 Transdermal Drug Delivery, Microneedles, and Drug Permeation
effect. It offers important advantages over oral and injectable routes, including avoidance of first-pass metabolism, improved patient compliance, and sustained drug release. However, the skin’s primary function
Opinion · 30 Jun 2025 Pulmonary Drug Delivery: Harnessing the Lungs for Therapeutics
their large surface area, thin epithelial barrier, rich blood supply, and avoidance of first-pass metabolism. Traditionally used for managing asthma and chronic obstructive pulmonary disease (COPD), pulmonary delivery

